Catalyst Wire Dossier Catalyst Wire Dossier

Huminsulin Normal

insulin
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Huminsulin Normal, covering 2015-12-24 to 2017-06-01. Get the full timeline:

Most recent: Clinical Trial Update: A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes [Phase 1, Phase 2]

See pricing